Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammationKarly C. Sourris, Melinda T. Coughlan, Phillip Kantharidis et al.|Kidney International|2023Cited by 121
A programmed decline in ribosome levels governs human early neurodevelopmentChunyang Ni, Elton Zeqiraj, Yudong Wei et al.|Nature Cell Biology|2025Cited by 14